N-amino methyl pentylamine | 82485-60-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-amino methyl pentylamine
• 英文别名: N'-pentylmethanediamine
• CAS: 82485-60-7
• 化学式: C₆H₁₆N₂
• 分子量: 116.206
• InChiKey: FVYLGFDTFBTOSR-UHFFFAOYSA-N

物化性质

• 沸点：
  170.6±8.0 °C(Predicted)
• 密度：
  0.829±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  8
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  38
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-amino methyl pentylamine 在 亚硝酸 作用下， 以59%的产率得到N-hydroxymethyl pentylamine
  参考文献：
  名称：

  Malik, Abdul; Afza, Nighat; Siddiqui, Salimuzzaman, Zeitschrift fur Naturforschung, Teil B: Anorganische Chemie, Organische Chemie, 1982, vol. 37, # 4, p. 512 - 518

  摘要：

  DOI：
• 作为产物：
  描述：

  pentyl cyanamide 在 盐酸 、 锌 作用下， 生成 N-amino methyl pentylamine
  参考文献：
  名称：

  Malik, Abdul; Afza, Nighat; Siddiqui, Salimuzzaman, Zeitschrift fur Naturforschung, Teil B: Anorganische Chemie, Organische Chemie, 1982, vol. 37, # 4, p. 512 - 518

  摘要：

  DOI：

文献信息

• Maytansines and maytansine conjugates
  申请人：——

  公开号：US20030109682A1

  公开（公告）日：2003-06-12

  Cytotoxin-targeting molecule conjugates comprising cytotoxin and an antibody, growth factor, or polysaccharide together with a pH-sensitive or redox potential-sensitive linker. Novel ansamitocins and recombinant genes and organisms that produce them. The use of the described conjugates in the treatment of cancer and other hyperproliferation diseases.

  细胞毒素-靶向分子共轭物，包括细胞毒素和抗体、生长因子或多糖，以及 pH 敏感或氧化还原电位敏感的连接体。新型ansamitocins和重组基因以及产生它们的生物体。所述共轭物在治疗癌症和其他过度增殖疾病中的应用。
• METHOD FOR PRODUCING AND STORING LIQUID COMPOSITION COMPRISING TETRAHYDRO-4H-1,3,5-OXADIAZINE-4-ONE
  申请人：Kao Corporation

  公开号：EP2915807B1

  公开（公告）日：2017-10-11
• METHODS OF TREATING TRAUMATIC BRAIN INJURY
  申请人：OXEIA BIOPHARMACEUTICALS, INC.

  公开号：US20170266257A1

  公开（公告）日：2017-09-21

  The present disclosure provides methods for treating traumatic brain injury and other neurological disorders in a subject in need thereof, comprising administering to the subject an effective amount of a composition comprising ghrelin or a ghrelin variant. This invention provides for methods for treating a severe or moderate traumatic brain injury in a patient wherein said method comprises administering to the subject suffering from said severe or moderate traumatic brain injury a therapeutic effective amount of ghrelin or a ghrelin variant or a composition comprising ghrelin or a ghrelin variant so as to treat said severe or moderate traumatic brain injury.
• CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METHODS OF THEIR PRODUCTION
  申请人：GLENMARK PHARMACEUTICALS S.A.

  公开号：US20190135918A1

  公开（公告）日：2019-05-09

  The present invention relates to hetero-dimeric immunoglobulins that target both a component of the human CD3 antigen and a component of the human CD38 antigen and methods of making the same. The present invention also relates to antibodies which bind to the human CD38 antigen and derivatives thereof for use as therapeutic or diagnostic reagents and methods of making the same.
• [EN] HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME<br/>[FR] COMPOSÉ HÉTÉROCYCLIQUE ET DISPOSITIF ÉLECTROLUMINESCENT ORGANIQUE UTILISANT CE COMPOSÉ<br/>[KO] 헤테로고리 화합물 및 이를 이용한 유기발광소자
  申请人：HEESUNG MAT LTD

  公开号：WO2016003171A1

  公开（公告）日：2016-01-07

  본 명세서는 신규한 헤테로고리 화합물 및 이를 이용한 유기발광소자에 관한 것이다.